BR9712134A - cidos hiidroxâmicos de b-sulfonila como inibidores de metaloproeinases de matriz. - Google Patents
cidos hiidroxâmicos de b-sulfonila como inibidores de metaloproeinases de matriz.Info
- Publication number
- BR9712134A BR9712134A BR9712134-7A BR9712134A BR9712134A BR 9712134 A BR9712134 A BR 9712134A BR 9712134 A BR9712134 A BR 9712134A BR 9712134 A BR9712134 A BR 9712134A
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- matrix
- metalloproeinases
- hydroxamic acids
- cycloalkyl
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000011159 matrix material Substances 0.000 title abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000008354 tissue degradation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
<B>áCIDOS HIDROXMICOS DE <225>-SULFONILA COMO INIBIDORES DE METALPROTEINASE DE MATRIZ<D>. a presente invenção fornece um composto da fórmula (I), ou seus sais farmacêuticos aceitáveis em que R~ 1~ é alquila C~ 4-12~, alquenila C~ 4-12~, alquinila C~ 4-12~, -(CH~ 2)~ h~-cicloalquila C~ 3-8~, -(CH~ 2~)~ h~-arila ou -(CH~ 2~)~ h~-het; R~ 2~ é alquila C~ 1-12~, alquenila C~ 2-12~, alquinila C~ 2-12~, -(CH~ 2~)~ h~-cicloalquila C~ 3-8~, -(CH~ 2~)~ h~-cicloalquila C~ 3-8~, -(CH~ 2~)~ h~-arila, -(CH~ 2~)~ h~-het, -(CH~ 2~)~ h~-Q, -(CH~ 2~)~ u~-X-R~ 4~ ou -(CH~ 2~)~ i~CHR~ 5~R~ 6~. Os compostos são inibidores de metaloproteinases de matriz envolvida na degradação de tecido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2684896P | 1996-09-27 | 1996-09-27 | |
PCT/US1997/016348 WO1998013340A1 (en) | 1996-09-27 | 1997-09-19 | β-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9712134A true BR9712134A (pt) | 1999-08-31 |
Family
ID=21834136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9712134-7A BR9712134A (pt) | 1996-09-27 | 1997-09-19 | cidos hiidroxâmicos de b-sulfonila como inibidores de metaloproeinases de matriz. |
Country Status (22)
Country | Link |
---|---|
US (2) | US5847153A (pt) |
EP (1) | EP0929519B1 (pt) |
JP (1) | JP2001516338A (pt) |
KR (1) | KR20000048639A (pt) |
CN (1) | CN1158254C (pt) |
AT (1) | ATE289590T1 (pt) |
AU (1) | AU726799B2 (pt) |
BR (1) | BR9712134A (pt) |
CA (1) | CA2266368A1 (pt) |
CZ (1) | CZ92399A3 (pt) |
DE (1) | DE69732571T2 (pt) |
EA (1) | EA001460B1 (pt) |
ES (1) | ES2236829T3 (pt) |
HK (1) | HK1022468A1 (pt) |
HU (1) | HUP0000145A3 (pt) |
ID (1) | ID21897A (pt) |
IL (1) | IL128900A0 (pt) |
NO (1) | NO312893B1 (pt) |
NZ (1) | NZ334729A (pt) |
PL (1) | PL332509A1 (pt) |
UA (1) | UA48262C2 (pt) |
WO (1) | WO1998013340A1 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69729007T2 (de) * | 1996-08-07 | 2005-04-07 | Darwin Discovery Ltd., Slough | Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung |
US6566384B1 (en) | 1996-08-07 | 2003-05-20 | Darwin Discovery Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
CZ92399A3 (cs) | 1996-09-27 | 1999-07-14 | Pharmacia & Upjohn Company | ß-sulfonylhydroxamové kyseliny jako inhibitory matriční metaloproteinázy |
AU5337498A (en) | 1997-01-22 | 1998-08-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted beta-thiocarboxylic acids |
GB9702088D0 (en) | 1997-01-31 | 1997-03-19 | Pharmacia & Upjohn Spa | Matrix metalloproteinase inhibitors |
US6172057B1 (en) * | 1997-02-27 | 2001-01-09 | American Cyanamid Company | N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
US6362183B1 (en) | 1997-03-04 | 2002-03-26 | G. D. Searle & Company | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
CN1253474A (zh) * | 1997-03-04 | 2000-05-17 | 孟山都公司 | 磺酰基二价芳基或杂芳基异羟肟酸化合物 |
US6063786A (en) * | 1997-11-12 | 2000-05-16 | Darwin Discovery, Ltd. | Heterocyclic compounds having MMP and TNF inhibitory activity |
US6187924B1 (en) * | 1997-11-12 | 2001-02-13 | Darwin Discovery, Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
JP2001524462A (ja) | 1997-11-21 | 2001-12-04 | ファーマシア・アンド・アップジョン・カンパニー | マトリックスメタロプロテイナーゼインヒビターとしてのβ−スルホニルヒドロキサム酸のα−ヒドロキシ、−アミノ及びハロ誘導体 |
PL200418B1 (pl) * | 1998-01-30 | 2009-01-30 | Darwin Discovery Ltd | Pochodna N-hydroksyformamidu, zawierający ją środek farmaceutyczny i jej zastosowanie |
EP0965592A1 (en) | 1998-06-18 | 1999-12-22 | F. Hoffmann-La Roche Ag | Process for preparing 3-arylsulfur hydroxamic acids |
GB9916562D0 (en) | 1999-07-14 | 1999-09-15 | Pharmacia & Upjohn Spa | 3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora |
US6620823B2 (en) | 2000-07-11 | 2003-09-16 | Bristol-Myers Squibb Pharme Company | Lactam metalloprotease inhibitors |
GB0017435D0 (en) * | 2000-07-14 | 2000-08-30 | Pharmacia & Upjohn Spa | 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivatives |
US20040225077A1 (en) | 2002-12-30 | 2004-11-11 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
WO2007070760A2 (en) * | 2005-12-15 | 2007-06-21 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
EP2081905B1 (en) | 2006-07-28 | 2012-09-12 | Boehringer Ingelheim International GmbH | Sulfonyl compounds which modulate the cb2 receptor |
JP5030114B2 (ja) | 2006-09-25 | 2012-09-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体をモジュレートする化合物 |
EP2217565B1 (en) * | 2007-11-07 | 2013-05-22 | Boehringer Ingelheim International GmbH | Compounds which modulate the cb2 receptor |
US8178568B2 (en) | 2008-07-10 | 2012-05-15 | Boehringer Ingelheim International Gmbh | Sulfone compounds which modulate the CB2 receptor |
KR20110063438A (ko) * | 2008-09-25 | 2011-06-10 | 베링거 인겔하임 인터내셔날 게엠베하 | Cb2 수용체를 선택적으로 조절하는 설포닐 화합물 |
US8299103B2 (en) * | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
US8383615B2 (en) | 2009-06-16 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
JP2013505295A (ja) * | 2009-09-22 | 2013-02-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を選択的に調節する化合物 |
JP2013517271A (ja) | 2010-01-15 | 2013-05-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
JP5746228B2 (ja) | 2010-03-05 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を選択的に調節するテトラゾール化合物 |
US8846936B2 (en) | 2010-07-22 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the CB2 receptor |
EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB689608A (en) * | 1950-04-13 | 1953-04-01 | Basf Ag | Improvements in the production of gamma-sulphonyl carboxylic acids |
US2659752A (en) * | 1951-08-09 | 1953-11-17 | Goodrich Co B F | Method for preparing beta-(arylsulfonyl) carboxylic acids and salts thereof |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
DE69309047T2 (de) * | 1992-04-07 | 1997-09-11 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
DE4233100A1 (de) * | 1992-10-01 | 1994-04-07 | Hoechst Ag | Verfahren zur stereoselektiven Synthese von 3-substituierten 2-Sulfonylmethylpropionsäuren sowie Zwischenprodukte |
DE4233099A1 (de) * | 1992-10-01 | 1994-04-07 | Hoechst Ag | Verfahren zur stereoselektiven Synthese von 3-substituierten 2-Thiomethylpropionsäuren |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
EP0640594A1 (en) * | 1993-08-23 | 1995-03-01 | Fujirebio Inc. | Hydantoin derivative as metalloprotease inhibitor |
GB9320660D0 (en) * | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
ATE225343T1 (de) * | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
DK0871439T3 (da) * | 1996-01-02 | 2004-08-02 | Aventis Pharma Inc | Substituerede (aryl, heteroaryl, arylmethyl eller heteroarylmethyl) hydroxamsyreforbindelser |
TW448172B (en) * | 1996-03-08 | 2001-08-01 | Pharmacia & Upjohn Co Llc | Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
CZ92399A3 (cs) * | 1996-09-27 | 1999-07-14 | Pharmacia & Upjohn Company | ß-sulfonylhydroxamové kyseliny jako inhibitory matriční metaloproteinázy |
US6362183B1 (en) | 1997-03-04 | 2002-03-26 | G. D. Searle & Company | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
-
1997
- 1997-09-19 CZ CZ99923A patent/CZ92399A3/cs unknown
- 1997-09-19 ID IDW990118A patent/ID21897A/id unknown
- 1997-09-19 EA EA199900332A patent/EA001460B1/ru not_active IP Right Cessation
- 1997-09-19 ES ES97945207T patent/ES2236829T3/es not_active Expired - Lifetime
- 1997-09-19 IL IL12890097A patent/IL128900A0/xx unknown
- 1997-09-19 PL PL97332509A patent/PL332509A1/xx unknown
- 1997-09-19 CN CNB971979227A patent/CN1158254C/zh not_active Expired - Fee Related
- 1997-09-19 US US08/934,408 patent/US5847153A/en not_active Expired - Fee Related
- 1997-09-19 AT AT97945207T patent/ATE289590T1/de not_active IP Right Cessation
- 1997-09-19 US US09/269,185 patent/US6235928B1/en not_active Expired - Fee Related
- 1997-09-19 EP EP97945207A patent/EP0929519B1/en not_active Expired - Lifetime
- 1997-09-19 KR KR1019990702581A patent/KR20000048639A/ko not_active Application Discontinuation
- 1997-09-19 CA CA002266368A patent/CA2266368A1/en not_active Abandoned
- 1997-09-19 AU AU46459/97A patent/AU726799B2/en not_active Ceased
- 1997-09-19 HU HU0000145A patent/HUP0000145A3/hu unknown
- 1997-09-19 NZ NZ334729A patent/NZ334729A/xx unknown
- 1997-09-19 WO PCT/US1997/016348 patent/WO1998013340A1/en not_active Application Discontinuation
- 1997-09-19 UA UA99042348A patent/UA48262C2/uk unknown
- 1997-09-19 BR BR9712134-7A patent/BR9712134A/pt active Search and Examination
- 1997-09-19 DE DE69732571T patent/DE69732571T2/de not_active Expired - Fee Related
- 1997-09-19 JP JP51570298A patent/JP2001516338A/ja not_active Withdrawn
-
1999
- 1999-03-26 NO NO19991494A patent/NO312893B1/no unknown
-
2000
- 2000-02-14 HK HK00100870A patent/HK1022468A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US6235928B1 (en) | 2001-05-22 |
NZ334729A (en) | 2001-01-26 |
CA2266368A1 (en) | 1998-04-02 |
AU4645997A (en) | 1998-04-17 |
WO1998013340A1 (en) | 1998-04-02 |
US5847153A (en) | 1998-12-08 |
KR20000048639A (ko) | 2000-07-25 |
HUP0000145A2 (en) | 2000-07-28 |
EP0929519A1 (en) | 1999-07-21 |
ID21897A (id) | 1999-08-05 |
UA48262C2 (uk) | 2002-08-15 |
EA199900332A1 (ru) | 1999-12-29 |
CN1230177A (zh) | 1999-09-29 |
EP0929519B1 (en) | 2005-02-23 |
ES2236829T3 (es) | 2005-07-16 |
DE69732571T2 (de) | 2006-01-12 |
ATE289590T1 (de) | 2005-03-15 |
NO991494L (no) | 1999-05-26 |
JP2001516338A (ja) | 2001-09-25 |
PL332509A1 (en) | 1999-09-13 |
DE69732571D1 (de) | 2005-03-31 |
NO312893B1 (no) | 2002-07-15 |
EA001460B1 (ru) | 2001-04-23 |
HK1022468A1 (en) | 2000-08-11 |
CZ92399A3 (cs) | 1999-07-14 |
HUP0000145A3 (en) | 2001-12-28 |
NO991494D0 (no) | 1999-03-26 |
IL128900A0 (en) | 2000-01-31 |
CN1158254C (zh) | 2004-07-21 |
AU726799B2 (en) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712134A (pt) | cidos hiidroxâmicos de b-sulfonila como inibidores de metaloproeinases de matriz. | |
BR0210874A (pt) | Derivados de tiazol-benzamida e composições farmacêuticas para a inibição da proliferação celular e métodos para o seu uso | |
BR9812095A (pt) | Compostos de indol como inibidores de cox-2 | |
BR0115452A (pt) | Compostos tendo atividade fungicida e processos para fabricação e uso dos mesmos | |
BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
BR0010555A (pt) | Inibidores de neuraminidases | |
AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
BR9806413A (pt) | Composto e uso do mesmo | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BR0213612A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
BR0110810A (pt) | Derivados de éter fenil-propargìlico | |
BR0113053A (pt) | Uso de benzilidenoaminoguanidinas e hidroxiguanidinas como ligantes para os receptores de melanocortina | |
BR0014060A (pt) | Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica | |
BR0109235A (pt) | Derivados do ácido carboxìlico como antagonistas ip | |
BR9809062A (pt) | Inibidores da metaloproteinase, composições farmacêuticas comtendo os mesmos e seus usos farmacêuticos | |
BRPI0008753B8 (pt) | composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida | |
BR0115291A (pt) | Derivados de 2-fenilaminoimidazolina fenil cetona substituìdos como antagonistas de ip | |
BR0308280A (pt) | Compostos oxo-azabicìclicos | |
BRPI0513084A (pt) | antagonistas duplos de nk1/nk3 contra esquizofrenia | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
BR0111142A (pt) | Utilização de derivados de biguanida ou de seus sais farmaceuticamente aceitáveis | |
BR9912612A (pt) | Composto de maleimida dissubstituìdo e seu usofarmacêutico | |
ES2196308T3 (es) | Derivado de 2-cianoiminoimidazol que inhiben la pde iv. | |
BR9813410A (pt) | Composto, formulação farmacêutica, uso de um composto, e, processos de tratamento de uma condição, em que a inibição de trombina é requerida ou desejada, e para a preparação de um composto. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] |